Can immunotherapy open the door to liver transplants for more cancer patients?
Disease control
Recruiting now
This study tests whether combining immunotherapy with a liver-directed tumor procedure can safely shrink liver cancer (hepatocellular carcinoma) enough to make patients eligible for a liver transplant. About 41 adults with advanced liver cancer will receive this combination thera…
Phase: PHASE2 • Sponsor: Ju Dong Yang • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC